DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
D•• C••••••••• H••••••• P•• L•• •
Pharmaceuticals)group grade Aon a schedule nowsponsor unattributed
Also written as: Arrotex; D•• C••••••••• H••••••• P•• L•• •dba Arrotex
Nothing material in the last 200 days. No dated change on record yet.
Mark path, consensus per quarter end
101¢ · 105¢ · 105¢Q4 2025 to Q2 2026
Principal held
at least $318M
sum of BDC pieces, a lower bound
Fair value
$186M
105c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Oct 29, 2032
no dated debt inside 24 months
On the tape since
Sep 30, 2025
latest Jun 30, 2026
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| G•••••• S•••• P•••••• C••••• C•••• | $318M | 105¢ | 0 pts |
Every BDC piece · 3 positions across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| G•••••• S•••• P•••••• C••••• C•••• | term loan first lien 1st L•••/S••••• S•••••• D••• I••••••• P••••••••• I••••••• R••• 9.62% R•••••••• R••• and S• | $241M | $165M 105c | //www.goldmansachsbdc.com/20260630#Bank Bill Swap Bid Rate BBSY+525 bp |
| G•••••• S•••• P•••••• C••••• C•••• | term loan first lien 1st L•••/S••••• S•••••• D••• I••••••• P••••••••• R•••••••• R••• and S••••• B + 5.25% M•••• | $42.7M | $-296,000 1741c | //www.goldmansachsbdc.com/20260630#Bank Bill Swap Rate BBSW+525 bp |
| G•••••• S•••• P•••••• C••••• C•••• | term loan first lien 1st L•••/S••••• S•••••• D••• I••••••• P••••••••• I••••••• R••• 9.68% R•••••••• R••• and S• | $35.0M | $21.3M 105c | //www.goldmansachsbdc.com/20260630#Bank Bill Swap Bid Rate BBSY+525 bp |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $318M | 105c | //www.goldmansachsbdc.com/20260630#Bank Bill Swap Bid Rate BBSY+525 bp | Oct 29, 2032 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $318M | $186M | 105c | 0 |
| Mar 31, 2026 | 1 | $318M | $186M | 105c | 0 |
| Dec 31, 2025 | 1 | $544M | $359M | 101c | 0 |
| Sep 30, 2025 | 1 | $318M | $0 | n/a | 0 |
What changed
- New borrower on a BDC scheduleSep 30, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- DBG CONSOLIDATEDderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Pharmaceuticals)reportedas one filer wrote it